POINT Biopharma Global Inc

+0.10 (+1.57%)
Earnings Announcements

Point Biopharma Global Posts Quarterly Loss Per Share Of 16 Cents

Published: 03/25/2022 12:59 GMT
POINT Biopharma Global Inc (PNT) - Quarterly Loss per Share $0.16.
Point Biopharma Global- As of Dec 31, 2021, Had About $238.8 Million in Cash and Cash Equivalents, Which is Anticipated to Fund Operations Into Q1 of 2024.
Q4 Earnings per Share View $-0.24 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.20

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.